MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Cardiovascular Systems Retained Earnings 2011-2026 | CSII
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Cardiovascular Systems
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -424 M | -381 M | -363 M | -330 M | -328 M | -329 M | -327 M | -271 M | -239 M | -203 M | -179 M | -162 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -162 M | -424 M | -295 M |
Quarterly Retained Earnings Cardiovascular Systems
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -443 M | -436 M | -424 M | -414 M | -404 M | -395 M | -381 M | -381 M | -369 M | -369 M | -363 M | -348 M | -345 M | -341 M | -330 M | -330 M | -331 M | -331 M | -328 M | -331 M | -332 M | -331 M | -329 M | -329 M | -328 M | -329 M | -327 M | -327 M | -300 M | -285 M | -271 M | -271 M | -252 M | -247 M | -239 M | -239 M | -219 M | -211 M | -203 M | -203 M | -190 M | -184 M | -179 M | -179 M | -170 M | -166 M | -162 M | -162 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -162 M | -443 M | -299 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M |  USA |
 |
Bruker Corporation
BRKR
|
2.41 B | $ 38.77 | -1.27 % | $ 5.78 K | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Cutera
CUTR
|
-303 M | - | -10.19 % | $ 1.99 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-157 M | $ 8.09 | 3.45 % | $ 581 M |  Israel |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Second Sight Medical Products
EYES
|
-122 M | - | -0.97 % | $ 54.4 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 4.1 | 2.76 % | $ 153 M |  France |
 |
Electromed
ELMD
|
21.2 M | $ 24.5 | 2.17 % | $ 207 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 9.69 | 3.09 % | $ 1.31 B | USA |
 |
FONAR Corporation
FONR
|
-33.6 M | $ 18.54 | 0.19 % | $ 122 M | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 42.93 | -1.11 % | $ 1.33 B | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
AxoGen
AXGN
|
-307 M | $ 29.44 | -1.31 % | $ 1.36 B | USA |
 |
Apyx Medical Corporation
APYX
|
-54.4 M | $ 3.26 | 2.84 % | $ 113 M | USA |
 |
InMode Ltd.
INMD
|
969 M | $ 13.55 | -0.37 % | $ 876 M | Israel |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
IRadimed Corporation
IRMD
|
56.8 M | $ 105.35 | 1.02 % | $ 1.33 B | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Accuray Incorporated
ARAY
|
-519 M | $ 0.52 | -0.36 % | $ 53.4 M | USA |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
LivaNova PLC
LIVN
|
-1.15 B | $ 66.26 | -3.17 % | $ 3.61 B |  Britain |
 |
Pulmonx Corporation
LUNG
|
-468 M | $ 1.47 | -3.92 % | $ 57.5 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-304 M | $ 0.79 | -1.75 % | $ 43 M | USA |
 |
Medtronic PLC
MDT
|
31.5 B | $ 96.0 | -0.75 % | $ 123 B | USA |
 |
Align Technology
ALGN
|
2.48 B | $ 181.73 | -0.5 % | $ 13.6 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Inari Medical
NARI
|
-46.8 M | - | - | $ 4.23 B | USA |
 |
Butterfly Network
BFLY
|
-802 M | $ 3.97 | 7.88 % | $ 840 M | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Abbott Laboratories
ABT
|
49.8 B | $ 113.65 | 0.04 % | $ 198 B | USA |
 |
NuVasive
NUVA
|
86.1 M | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
-813 M | - | - | $ 217 M | USA |
 |
BioSig Technologies
BSGM
|
-255 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
5.57 B | $ 72.77 | -1.46 % | $ 108 B | USA |
 |
Orthofix Medical
OFIX
|
-368 M | $ 12.98 | -0.42 % | $ 514 M |  Curacao |